ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 32640720

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis.

Ratnayake B and 7 others. J Clin Med, 2020. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis. Papers, record 32640720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32640720

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis.
PubMed
Journal
J Clin Med
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2020-09-28
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ratnayake BBathiyahttps://orcid.org/0000-0002-5188-9124
2Savastyuk AYAlina Y
3Nayar MManu
4Wilson CHColin H
5Windsor JAJohn A
6Roberts KKeith
7French JJJeremy J
8Pandanaboyana SSanjayhttps://orcid.org/0000-0003-3099-2197

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,275,632Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.JAMA Surg2016https://conductscience.org/library/papers/27275632PubMed
221,159,106Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival.HPB (Oxford)2011https://conductscience.org/library/papers/21159106PubMed
331,325,134Efficacy of Neoadjuvant Chemotherapy in Distal Pancreatectomy with En Bloc Celiac Axis Resection (DP-CAR) for Locally Advanced Pancreatic Cancer.J Gastrointest Surg2020https://conductscience.org/library/papers/31325134PubMed
424,075,521Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer.Pancreatology2013https://conductscience.org/library/papers/24075521PubMed
517,533,388A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.Br J Cancer2007https://conductscience.org/library/papers/17533388PubMed
625,599,322Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.Ann Surg2015https://conductscience.org/library/papers/25599322PubMed
715,120,377A reappraisal of preoperative chemoradiation for localized pancreatic head ductal adenocarcinoma in a 5-year single-institution experience.J Gastrointest Surg2004https://conductscience.org/library/papers/15120377PubMed
818,308,215Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.J Am Coll Surg2008https://conductscience.org/library/papers/18308215PubMed
919,273,710DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.J Clin Oncol2009https://conductscience.org/library/papers/19273710PubMed
1022,065,318Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.J Gastrointest Surg2012https://conductscience.org/library/papers/22065318PubMed

1 to 10 of 66

See all 66 references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42,582,406Comparison of postoperative survival after neoadjuvant treatment versus upfront surgery in resected pancreatic ductal adenocarcinoma: a propensity score matching analysis.Ann Surg Treat Res2026https://conductscience.org/library/papers/42582406PubMed
42,174,653Extracellular vesicles from chemotherapy-induced senescent tumor cells reprogram hepatic phospholipid metabolism to promote pancreatic cancer liver metastasis.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42174653PubMed
41,816,565The role of chemoradiotherapy after induction in locally advanced pancreatic cancer: lessons learnt from CONKO-007.J Gastrointest Oncol2026https://conductscience.org/library/papers/41816565PubMed
40,342,759Recurrence after neoadjuvant therapy for pancreatic cancer: same challenges, new opportunities.Hepatobiliary Surg Nutr2025https://conductscience.org/library/papers/40342759PubMed
40,226,170Impact of portal/superior mesenteric vein abutment angle on prognosis in pancreatic cancer: a single-center retrospective cohort study.Ann Surg Treat Res2025https://conductscience.org/library/papers/40226170PubMed
39,779,977Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma.Exp Mol Med2025https://conductscience.org/library/papers/39779977PubMed
39,678,426Recurrent neurogenic shock as a rare postoperative complication associated with pancreaticoduodenectomy with mesopancreas excision in elderly patient: a case report.Gland Surg2024https://conductscience.org/library/papers/39678426PubMed
39,656,390Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas.Ann Surg Oncol2025https://conductscience.org/library/papers/39656390PubMed
39,323,995Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer.Front Oncol2024https://conductscience.org/library/papers/39323995PubMed
38,036,745Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer.Nat Rev Gastroenterol Hepatol2024https://conductscience.org/library/papers/38036745PubMed

1 to 10 of 18

See all 18 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32640720

GET https://conductscience.org/api/papers/v1/32640720/references?page=2

API referenceFor AI assistants